Hysteroscopy surgery
Conditions
Interventions
Experimental group:All patients were injected with intravenous tilgilidine fumarate for 9 minutes 10 minutes before operation, and propofol 2 mg/kg 1 minute before surgery. The initial dose of Tygilid
Sponsors
Lianyungang Maternal and Child Health Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Patients undergoing elective hysteroscopic surgery; 2. Age 18-60 years old; 3. ASA classification I.-II; 4.BMI18-25kg/m^2 ; 5. No respiratory disease and normal airway assessment before surgery.
Exclusion criteria
Exclusion criteria: 1. Refusal to sign informed consent; 2. Allergy to experimental drugs; 3. Abnormal vital signs or abnormal clinical laboratory test results; 4. Long-term use of opioids, analgesics, sedative drugs or a history of alcoholism; 5. Have a mental illness or are unable to communicate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The 90% effective dose of tegileridine for inhibiting the cervical dilation response; | — |
Secondary
| Measure | Time frame |
|---|---|
| The general information of the patient, including age, height, weight, BMI, ASA classification and the name of the proposed surgical procedure, etc.;Total amount of propofol;The patient's heart rate at admission, successful induction, end of examination, and discharge;Adverse reactions include nausea, vomiting, asphyxia, dizziness, hypoxemia, bradycardia and hypotension.;Titili fumarate quantitative;Number of body motor reactions;Time to recovery from anesthesia (time from stopping propofol to opening the eyes as instructed);Check the time;Pain score upon exit from the PACU;Non-invasive blood pressure;Oxygen saturation; | — |
Countries
China
Contacts
Public ContactYan Jiane
Lianyungang Maternal and Child Health Hospital
Outcome results
None listed